(2). Also, irradiation experiments were performed in the presence of the nucleobase derivatives 9-ethylguanine (9-EtG) and 9-ethyladenine (9-EtA). Formation of Ru-9-EtG adducts was observed after 3 h irradiation by NMR and HR-MS, while only very small amounts of a Ru-9-EtA adduct could be detected by HR-MS. Solution structural data were obtained by X-ray absorption spectroscopy (XAS) for both 1 and 2. EXAFS gave a Ru-Cl distance of 2.416(7) Å for 1, and a Ru-O H2O distance of 2.102(6) Å for 2. DFT and TDDFT were employed to study the photophysical and photochemical properties of 1. Calculations show that dissociative metal-centered states can be related to the light-induced release of a Cl ligand and subsequent coordination of a solvent molecule. The compound showed no antiproliferative activity in three human carcinoma cell lines (lung, bladder, pancreas) under the testing conditions, either with or without irradiation with UV-light.
Introduction
Ruthenium bipyridyl complexes are well known for their photophysical and photochemical properties, which have been successfully exploited for biomedical and biophysical applications. 1 In particular, their absorption and emission features have been used to investigate the ability of these ruthenium derivatives to interact with bio-macromolecules, such as proteins and DNA. 2 Furthermore, ruthenium complexes show potential as alternatives to platinum derivatives in chemotherapy 3 and two ruthenium(III) complexes, namely NAMI-A 3a,4 and KP1019, 5 are on clinical trial. Several Ru(II) bipyridyl complexes have been studied as possible anticancer agents as well. A number of studies indicate that the most lipophillic molecules are often the most cytotoxic and that DNA does not seem to be a target for this family of compounds.
Confocal microscopy highlights that ruthenium(II) bipyridyl dyes do not accumulate in the nucleus, and that their cellular uptake occurs either by endocytosis or by active transport, depending on the structure of the complex. 6 In the case of E. coli the outer membrane protein OMPF appears to be involved in the transportation of polypyridyl ruthenium complexes into the cells. 7 However, a few cases in which ruthenium polypyridyl complexes are able to bind DNA or DNA bases have been reported. 8 Among these, [Ru(bpy) 2 Cl 2 ] (where bpy = 2,2′-bipyridine) was found to be inactive towards murine and human tumor cell lines, while
[Ru(terpy)Cl 3 ] (where terpy = 2,2′;6′,2′′-terpyridine) showed remarkably high cytotoxicity. 9 To explore further the promising field of metal-based photochemotherapy, 10 we have recently investigated the design of new photoactivable ruthenium complexes. 11 When irradiated with visible light, these are able to release a coordinated ligand and form a reactive aqua species which can subsequently bind to DNA bases. Due to their rich photochemistry and synthetic versatility, ruthenium bipyridyl complexes are strong candidates for designing new anticancer prodrugs that can be activated by light excitation. The photoproducts can display different reactivity and cell distribution properties compared to ground-state metal complexes (prodrugs), and therefore light activation can be employed to extend the variety of biomacromolecules targeted by this class of complexes. 4, 12 Also photoactivation is able to limit the effects of cytotoxic species to irradiated areas, thus allowing specific tissues to be targeted within an organism.
In this study we describe the structural, photochemical and nucleobase binding properties of the ruthenium carbonyl complex cis-[Ru(bpy) 2 (CO)Cl] + (1) . Complex 1 has been previously studied as a photocatalyst for the water gas shift reaction 13 and for CO 2 photoreduction. 14 Although there has been some disagreement 13,14,16a UV-visible, XAS and DFT calculations) were carried out to elucidate the mechanism of ligand photodissociation from 1. Nucleobase binding experiments with 9-ethylguanine (9-EtG) and 9-ethyladenine (9-EtA) using NMR and mass spectrometry both in the dark and under irradiation were performed to investigate whether complex 1 might be a candidate for photoactivated targeting of DNA in cells.
Experimental Section
Materials. All solvents and reagents in the synthetic procedures were of analytical/reagent grade and used as received. Ruthenium(III) chloride hydrate was purchased from Lancaster.
Lithium chloride, sodium perchlorate, 9-ethylguanine and 9-ethyladenine were purchased from Aldrich and used without further purification. 2,2′-bipyridine, obtained from Aldrich, was purified by crystallization from hexane. program, 18 employing the DFT method. The ground state geometry optimization was performed in the gas phase at two different levels of theory: PBE1PBE 19 /LanL2DZ/6-31G** (BS1 level) and B3LYP 20 /LanL2DZ/6-31G** (BS2 level); the LanL2DZ 21 basis set and effective core potential was employed for the Ru atom, while the 6-31G** 22 basis set was used for all other atoms. The lowest-lying triplet state geometry was optimized in the gas phase using the unrestricted Kohn-Sham formalism (UKS). 23 The nature of all stationary points was confirmed by normal-mode analysis.
Thirty-two singlet electronic transitions were calculated by TDDFT, 24 employing the ground state structures optimized at the BS1 and BS2 level and including the solvent effect using the CPCM 25 method, with water as solvent. For the TDDFT calculations, either the 6-31G** (BS1a and BS2a) and the 6-311G** 22 (BS1b and BS2b) basis sets were employed (6-31G** and 6-311G** were used for the Cl, O, N, C, H atoms, while the LanL2DZ was used for Ru).
The program GaussSum 1.05 26 was used to simulate the electronic spectra of the ruthenium complex and to visualize the singlet excited state transitions as electron density difference maps (EDDMs). coefficient between one and two and an edge step close to one. A minimum of five energy scans were acquired for each sample to achieve high signal-to-noise ratio, and averaged after (k) extraction. 29 EXAFS analyses were conducted in the 4-18 Å -1 range, starting from structures optimized by DFT calculations. Fits were performed in k-space, without Fourier filtering, in order to avoid mathematical artifacts. EXAFS data analysis was performed using the ESTRA and FITEXA software, 30 which is an evolution of the Frascati code. 31 The code exploits the minimization routines of the MINUIT code 32 . Antiproliferative activity. Cytotoxicity of 1 was determined by the crystal violet assay. Experiments were performed in triplicate.
Results and Discussion
Structural and electronic properties. The X-ray absorption spectra of the chlorido complex 1 and aqua complex 2 were acquired to investigate the solution structures of the complexes and are shown in Figure 1 . Data for both complexes could be fitted with structural parameters that are consistent with the computed structures, and in the case of 1 also with the crystal structure.
XANES (X-ray Absorption Near-Edge Structure) is sensitive to electronic properties, geometry and local structure surrounding the absorber atom (ruthenium). The similarity of the two XANES spectra suggests that the substitution of a Cl ligand with a water molecule leaves almost unchanged the local coordination and geometry of all remaining ligands around the metal center. Moreover, the lack of any detectable shift in the absorption edge energy position confirms that ruthenium has the same oxidation state and the same electronic configuration both in 1 and 2.
The EXAFS (Extended X-ray Absorption Fine Structure) signals and the corresponding fit In both k-( Figure 2A ) and R-spaces ( Figure 2B and 2C) , there is a good correspondence between the experimental and theoretical curves. In the EXAFS spectrum of 2, the loss of the Ru-Cl contribution (substitution of Cl with H 2 O) results in an increase of the first shell signal, due to the fact that Ru-Cl and Ru-O paths are out of phase in a large region of the kspace. 36 This also has little effect on the higher shell signal (2.2-3.5 Å), as well evidenced by the imaginary parts ( Figure 2C ) of both spectra. Such EXAFS features confirm the XANES observation that the ligand substitution hardly affects both distances and geometries of the CO and bpy ligands.
The data for complex 1 were fitted by refining thirteen independent parameters and for complex 2 with eleven. All paths have the same amplitude reduction (S 0 2 ) and energy shift ( E) factors. For complex 2 Ru-O H2O and Ru-N paths were fitted using the same distance parameters and Debye-Waller factors, because the difference in the length is below the resolution limit and EXAFS chemical selectivity is limited to z = 4.
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Refined structural parameters obtained from the EXAFS fit are reported in Table 1 . In cases where the higher shell distances is due to metal carbonyls only, also the C-O distance of the CO molecule can be determined with EXAFS. 38 In the present case and in others successfully solved, 39 the co-presence of scattering contributions involving the carbon atoms of the bpy ligands imposes a constraint on the C-O distance to the expected value in the gas phase (1.128 Å).
Structural parameters from DFT were compared to X-ray diffraction (XRD) data for complex 1 only, 16a while comparison with EXAFS data was performed for both complexes (Table 2) .
DFT bond distances and angles are in good agreement with XRD data, the only exception being the N2-Ru-Cl angle which is strongly distorted in the XRD structure due to the crystal packing. 16a EXAFS data are also in good agreement with both XRD data and DFT calculations. Considering the lower resolution of EXAFS technique, the three approaches Thirty-two singlet transitions were calculated by TDDFT to assign the UV-visible absorption spectrum of 1, employing the ground-state structures optimized at the BS1 and BS2 level. For each geometry and functional, either the 6-31G** or the 6-311G** basis set were used for the Cl, O, N, C, H atoms (while the LanL2DZ was employed for Ru). No significant difference was found between the calculations; only, a ca. 20-nm red-shift of the two lowest-energy singlet transitions was observed when the B3LYP functional was used and when the 6-311G** basis set was employed. The lowest-lying triplet state geometry was calculated with the unrestricted Kohn-Sham method. 23 The spin density surface and the SOMOs (Supporting Information) highlight the MC nature of this state, which is consistent with the lack of emission of 1 in several solvents and to its photochemical behaviour. Figure 5 shows that 1 is completely converted into 2 after 3 h of irradiation with white light at ca. 1 J/cm 2 h. During irradiation and conversion of 1 into 2, the pH of the solution changes from 7.3 to 5.3. Since the pK a of the Ru OH 2 /OH equilibrium for complex 2 is 8.3, 13 the photo-hydrolysis product believed to prevail in solution is cis-
. Hydrolysis of the Ru-Cl bond occurs also in the dark, however the thermally-activated reaction is significantly slower compared to the photoinduced hydrolysis.
In fact, at ca. 310 K twelve hours are required to reach a 50% conversion of 1 (data not shown), while under irradiation the reaction is complete after three hours. Significantly, the 1 H NMR spectra of the reaction products obtained by light-and thermal-activation are identical, confirming that in both cases 2 is formed. Irradiation of 1 in the presence of 9-ethylguanine, 9-EtG, (ca. 1:1.5 ratio, pH = 6. (blue arrows in Figure 6 ) at 7.04 and 6.77 ppm. Both these signals can be assigned to the H8 of 9-EtG of two different Ru-guanine adducts, which are present at 16% and 25% in comparison to 2, as determined from the 1 H NMR peak areas. The shift of the H8 signal for these two species is consistent with the shielding effect induced by the ring current of the bpy ligands. 8d Using 2D 1 H-1 H TOCSY and NOESY NMR data, it was possible to confirm that the singlet at 6.77 ppm corresponds to a metal-nucleobase species. In particular, a crosspeak between the H8 of 9-EtG and a bpy proton was observed in the NOESY spectrum.
Interestingly, when the same solution was left in the dark at 310 K, the 1 H NMR spectrum did not show any formation of Ru-9-EtG adducts, even after 24 h. The presence of two adducts can be ascribed to the loss of CO, possibly caused by prolonged irradiation of the photoproduct 2. Binding through the N1 of 9-EtG can be ruled out due to steric hindrance (from modelling, not shown). In particular, the singlet at 6.77 can be assigned to the H8 proton of cis-[Ru(bpy) 2 Cl(9-EtG)] + , a species previously isolated and crystallized after the hydrolysis of cis-[Ru(bpy) 2 Cl 2 ] in the presence of 9-EtG. 8d Hence it appears that released Cl -ions can re-coordinate after CO displacement.
When the irradiated solution of 1 and 9-EtG was analyzed by ESI-HR-MS, a major peak was observed in the spectrum corresponding to complex 2 (calcd.: 459.0395, found: 459.0421).
Another major ion (m/z = 296) yielded the molecular formula C 27 H 25 N 9 ORu 2+ (calcd.:
296.5611, found: 296.5583), consistent with the species {[Ru(bpy) 2 (9-EtG)]} 2+ , therefore confirming ruthenation of the nucleobase.
Reaction of complex 1 with 9-ethyladenine (9-EtA) was investigated both in the dark (pH = 6.5) and under irradiation. Formation of adducts between the metal complex and the adenine derivative were not observed by 1 In view of the finding that light can activate complex 1 toward binding to guanine, a potential nucleobase target in DNA, we investigated the photocytotoxicity of the complex towards three different human carcinoma cell lines.
Antiproliferative activity. Complex 1 was found to be non-toxic to human urinary bladder 
Conclusions
We Figure 1 . XANES and EXAFS X-ray absorption spectra of 1 (red line) and 2 (blue line).
Inset: structural scheme used to construct SS and MS paths for the EXAFS data analysis. the solution structures of 1 and 2 were obtained by EXAFS, and DFT calculations provided insights into the mechanism of photoactivation of the chloride complex. Although photoinduced formation of 9-ethylguanine (9-EtG) nucleobase adducts by 1 was observed, the complex was not phototoxic to cancer cells.
